Open payments



















Mimedx will be sold before the end of the year. Once the trials stopped and our pipeline dried up, it is apparent that Cap is doing away with all wasteful revenue avenues trying to increase its value. Hopefully the stock price will continue to increase so we can finally put this dying dog down and end the suffering.